December 7, 2010

WASHINGTON — Proclaiming the potential cost-saving benefits of its signature legislative accomplishment, the massive health-reform bill enacted earlier this year, the White House is projecting that the Affordable Care Act will reduce average costs per patient enrolled in Medicare by thousands of dollars over the next decade.


December 1, 2010

Drug maker Savient Pharmaceuticals has begun shipping its new gout treatment to specialty distributors, the company said Tuesday.

November 30, 2010

Recent public perception that the Food and Drug Administration had not been doing its job — ensuring that Americans' approved medical devices and medicines are relatively safe — may be impeding fast approval processes, according to a new PricewaterhouseCoopers report published Tuesday.

November 24, 2010

More than ever, seniors who rely on Medicare need to carefully evaluate the dizzying array of prescription drug plan choices available to them, as the 2011 enrollment period for Medicare Part D drug benefit program goes into high gear, independent pharmacy leaders declared Tuesday.

November 24, 2010

Most of the newly elected and re-elected Republican members of Congress, Tea Party candidates in particular, vowed to whittle down or repeal healthcare reform once in office, but the healthcare companies that stand to benefit hope to change their minds, as some of their lobbying activities last quarter have shown.

November 24, 2010

UnitedHealth Group will start a program next year that it said can reduce drug costs to as low as $2 per script, the company said Tuesday.

November 22, 2010

A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site ...

November 22, 2010

Several organizations want Congress to reverse a provision in the healthcare-reform act that would prohibit the use of FSAs to purchase OTC medicines without a prescription ...

November 22, 2010

Several organizations want Congress to reverse a provision in the healthcare-reform act that would prohibit the use of FSAs to purchase OTC medicines without a prescription ...

November 22, 2010

WOODCLIFF LAKE, N.J. Par Pharmaceutical has begun shipments of a generic treatment for asthma, the drug maker said Monday.

Par announced that it started shipping zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a generic version of AstraZeneca’s Accolate.

Accolate has sales of $50 million in the United States per year, according to IMS Health.

November 22, 2010

The pharmaceutical lobby spent more than $5 million lobbying the government during the third quarter ...

November 21, 2010

Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug...

November 21, 2010

A drug maker will pull a common prescription painkiller from the market following the release...

November 18, 2010

One of the Big Three in pharmaceutical wholesaling is about to get a lot bigger....

November 18, 2010

Johnson & Johnson and the U.S. government are suing two generic drug makers to stop...

November 17, 2010

Cardinal Health is looking to expand the pharmaceutical segment of its business by acquiring a...

November 17, 2010

A coalition of six associations, including the Consumer Healthcare Products Association and the National Association...

November 16, 2010

With the holiday season just around the corner, CVS/pharmacy is encouraging older adults and their...

November 15, 2010

The U.S. District Court for the District of Delaware has upheld a patent held by...

November 15, 2010

The Food and Drug Administration has approved a generic treatment made by Impax for seasonal...

November 15, 2010

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...

November 15, 2010

The Centers for Medicare and Medicaid Services has proposed a rule shortening the traditional 30-day...

November 15, 2010

The Food and Drug Administration has granted orphan drug designation to a drug for treating...

November 14, 2010

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...